Research.Patient.info
locally advanced pancreatic cancer research hub
2 indexed studies · 0 currently recruiting
- authorisedTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects with Locally Advanced Pancreatic Adenocarcinoma
This study is looking at a new medicine called Ampligen for people with pancreatic cancer that has spread nearby but not to other parts of the body. It aims to see if Ampligen can stop the cancer from growing for longer. It's in an early stage of testing.
Netherlands - active not recruitingPHASE2
FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma
This study looks at a new treatment called OncoSil™ alongside standard chemotherapy (FOLFIRINOX) for locally advanced pancreatic cancer. Researchers want to see if adding OncoSil™ is safe and effective for people who haven't had previous treatment for their pancreatic cancer.
Australia · Belgium · Italy